AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, TGF‐β1 was enriched in the EVs of CML cells and can stimulate CML cell proliferation by activating ERK, AKT, and anti‐apoptotic pathways (Figure 5C).